Home » Topics » BioWorld Science

BioWorld Science
RSS

ADGRL1 haploinsufficiency linked to neurodevelopmental disorders

June 15, 2022

Aqilion receives clearance for phase I study of AQ-280 for eosinophilic esophagitis

June 15, 2022

National Center for Geriatrics & Gerontology synthesizes acyclic retinoid derivatives

June 15, 2022

A&J Science synthesizes new antibacterials

June 15, 2022

Beijing Jacobio Pharmaceuticals identifies new GTPase KRAS inhibitors

June 15, 2022

Deciphera Pharmaceuticals discloses PERK and/or GCN2 inhibitors

June 15, 2022

Vanderbilt University patents new muscarinic M4 receptor antagonists

June 15, 2022

Q-griffithsin: an antiviral lectin for COVID-19

June 15, 2022

Accumulation of aberrant acylation PTMs on critical metabolic enzymes underlies MMA

June 15, 2022

EHA 2022 presentations describe sickle cell disease headway and headwinds

June 14, 2022

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...